Studying how cancer cells adapt to and survive under the nutritional context of the tumor microenvironment (TME). Building a multi-omics based metabolic profile of pancreatic ductal adenocarcinoma (PDAC) cells under TME nutrient levels.
Working at the interface of the research lab and clinic, our group is identifying mechanisms of resistance to anti-androgen therapies in advanced prostate cancer and translating these discoveries into improved treatment strategies for patients.
My previous research at Ohio University investigated ATP as a modulator of epithelial to mesenchymal transition / metastasis in lung cancer. My current research interests are in blood cancers, cancer immunology, cancer metabolism, and metastasis.